Chemotherapy De-Escalation Associated With Excellent HR+/HER2+ Breast Cancer Survival
Patients with hormone receptor-positive (HR+)/HER2+ early breast cancer who were treated with neoadjuvant (presurgical) endocrine therapy or chemotherapy plus Herceptin ...